well thanks for the acknowledgement luncha - back on the 14th i was amused that the buy depth had vanished - an error maybe? - a lack of support?, doubt it - something up ?, proved correct.
blind freddy knew something was gonna happen someday, with the consolidation in europe and so many oncology groups missing out - myp was a prime target - but timing was a little sooner than expected.
so now its hope for rumours to drive the price back above $4.20 to maximise sale price, then await for a takeover of syb, which thankfully missed out on the sds prize today - keeps them within range.
MYP
mayne pharma limited
silence is golden: apparently, page-2
Add to My Watchlist
What is My Watchlist?